# Grand Pharmaceutical Group

- Headquarters: China
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Sites

| Place | Latest | Largest value | Types |
| --- | --- | --- | --- |
| Canada | 2017-11-15 | $7.50M | investment |

## Customers, suppliers and deals

- [CardioFocus, Inc.](https://endata.com/companies/39116.md): supplier, 1×, latest 2021-05-30
- [Donghai Capital](https://endata.com/companies/28077.md): partner, 1×, latest 2017-11-13

## Announcements (4)

- 2021-05-30: [Grand Pharmaceutical Group licenses HeartLight X3 laser ablation platform from CardioFocus](https://endata.com/announcements/58608-grand-pharmaceutical-group-licenses-heartlight-x3-laser-ablation-platform-from) (Contract · China · $20.0M)
- 2020-07-27: [Grand Pharma subsidiary to acquire Nanjing Kainite Medical Technology](https://endata.com/announcements/50456-grand-pharma-subsidiary-to-acquire-nanjing-kainite-medical-technology) (Acquisition · Nanjing, China · $4.20M)
- 2017-11-15: [Grand Pharma joint venture invests $7.5M in Conavi Medical](https://endata.com/announcements/26625-grand-pharma-joint-venture-invests-7-5m-in-conavi-medical) (Investment · Canada · $7.50M)
- 2017-11-13: [Grand Pharma and Donghai Capital to form joint venture for cardiovascular medical devices](https://endata.com/announcements/26560-grand-pharma-and-donghai-capital-to-form-joint-venture-for-cardiovascular) (Partnership · Hong Kong, Hong Kong SAR China · $15.0M)

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.